FLI and FIB-4 in diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease in Primary Care: High Prevalence and Risk of Significant Disease. Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;

Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury Nelia Hernandez; Fernando Bessone; Raul Andrade;

Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis Koos de Wit; Diederick J. van Doorn; Bregje Mol; Lonneke A. van Vught; Frederik Nevens; Ulrich Beuers; Cyriel Y. Ponsioen; Charlotte E. Teunissen; R. Bart Takkenberg;